Safety and Immunogenicity of a Plant-Produced Recombinant Hemagglutinin-Based Influenza Vaccine (HAI-05) Derived from A/Indonesia/05/2005 (H5N1) Influenza Virus: A Phase 1 Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study in Healthy Adults

By Chichester Jessica A.   Jones R. Mark   Green Brian J.   Stow Mark   Miao Fudu   Moonsammy George   Streatfield Stephen J.   Yusibov Vidadi  

Viruses, Vol. 4, Iss. 11, 2012-11 ,pp. : 3227-3244

MDPI

Access to resources Recommend Favorite

Development of Live-Attenuated Influenza Vaccines against Outbreaks of H5N1 Influenza

By Zheng Dan   Yi Yinglei   Chen Ze  

Viruses, Vol. 4, Iss. 12, 2012-12 ,pp. : 3589-3605

MDPI

Access to resources Recommend Favorite

Molecular and epidemiological analysis of pandemic and post‐pandemic influenza A(H1N1)pdm09 virus from central India

By  

JOURNAL OF MEDICAL VIROLOGY, Vol. 90, Iss. 3, 2018-03 ,pp. : 447-455

John Wiley & Sons Inc

Access to resources Recommend Favorite

Advances and Future Challenges in Recombinant Adenoviral Vectored H5N1 Influenza Vaccines

By Zhang Jianfeng  

Viruses, Vol. 4, Iss. 11, 2012-11 ,pp. : 2711-2735

MDPI

Access to resources Recommend Favorite

Large Scale Genome Analysis Shows that the Epitopes for Broadly Cross-Reactive Antibodies Are Predominant in the Pandemic 2009 Influenza Virus A H1N1 Strain

By Lara-Ramírez Edgar E.   Segura-Cabrera Aldo   Salazar Ma Isabel   Rodríguez-Pérez Mario A.   Guo Xianwu  

Viruses, Vol. 5, Iss. 11, 2013-11 ,pp. : 2796-2802

MDPI

Access to resources Recommend Favorite